# CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer

> **NCT04310774** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Cervical Cancer
- Chemotherapy

## Interventions

- **DRUG:** Tegafur, Gimeracil and Oteracil Potassium Capsules (one drug)

## Key facts

- **NCT ID:** NCT04310774
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-15
- **Primary completion:** 2024-04-15
- **Final completion:** 2026-04-15
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04310774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04310774, "CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04310774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*